Stock listing
OCC Stock Price, News, Filings & Events — Orthocell Ltd
Selected listing: OCC · ASX · AUD · AU
This page tracks Orthocell Ltd's OCC:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following OCC:ASX. OCC:ASX is the stock-level entry point for investors researching Orthocell Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Orthocell Ltd (Ticker: OCC) is a public company based in Australia, focusing on innovative regenerative medicine solutions. With a market capitalization of approximately AUD 141.88 million, Orthocell is dedicated to developing advanced therapies for tissue repair and regeneration. The company's commitment to research and development aims to improve patient outcomes in various medical fields.

- Ticker
- OCC:ASX
- Asset type
- Stock
- Market cap
- $141.2M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- ASX
- Currency
- AUD
Orthocell Ltd OCC:ASX stock context
This page tracks Orthocell Ltd's OCC:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following OCC:ASX. OCC:ASX is the stock-level entry point for investors researching Orthocell Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Orthocell Ltd (Ticker: OCC) is a public company based in Australia, focusing on innovative regenerative medicine solutions. With a market capitalization of approximately AUD 141.88 million, Orthocell is dedicated to developing advanced therapies for tissue repair and regeneration. The company's commitment to research and development aims to improve patient outcomes in various medical fields.
Latest news from Orthocell Ltd
Q4 FY26 ASX Investor Presentation
July 13, 2026
Orthocell Appoints Thailand Distributor for Remplir
July 2, 2026
Remplir™: Australian Nerve Repair Device Supports Victims of War in Ukraine
June 28, 2026
First Sales of Remplir Achieved in US$75m Canadian Market
April 29, 2026
Compelling 90% Success Rate for Remplir in Real World Study
April 27, 2026
Research Orthocell Ltd
Orthocell Ltd investor report
Review AI stock analysis and investor report context for OCC:ASX.
Orthocell Ltd company profile
View the public company page for Orthocell Ltd on 6ix.
Orthocell Ltd news
Read company news and market updates connected to Orthocell Ltd.
Orthocell Ltd investor events
Find investor webinars, events, and replay context for Orthocell Ltd.